.png?width=2400&height=263&name=Emergent-BioServices_CMYK_Logo-Tagline-Lockup%20(2).png "Emergent BioSolutions CDMO"){kind=logo}
10.04.2022
Focus on Fill and Finish
Kelly Christiansen, vice president & general manager of Emergent CDMO's Rockville drug product manufacturing facility recently...
News & Insights
Emergent CDMO News, Insights & Events
When a company develops, manufactures and delivers vaccines and therapeutics that take on the most serious global health threats, it’s not surprising to see their name in the headlines. And we are honored that for more than 20 years, Emergent has been one of those names. Included below are prominent news and feature stories that profile a range of our accomplishments through the years as well as advancements we’ve made in the technologies, processes and expertise needed to serve as a premier CDMO.
09.01.2022
EXECUTIVE INTERVIEW – Emergent CDMO: A Molecule-to-Market Partner for Complex Biologics
For nearly 25 years, Emergent has developed, manufactured, and delivered their own innovative vaccines and biotherapeutic...
08.17.2022
How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines
Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...
06.24.2022
On Demand Webinar: High-Speed Viral Drug Product Manufacturing
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...
05.11.2022
Learn more about our site in Switzerland
Located in Thörishaus, Switzerland, just outside of Bern, our European-based site has expertise in mammalian, microbial, and...
04.14.2022
Molecule to Market: Inside the Outsourcing Space
Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...